Arachidonic acid [20:4(N-6)] has been implicated in neurological damag
e induced by cerebral ischaemia. Membrane arachidonate concentrations
can be reduced by changes in dietary fat intake. Therefore, in the pre
sent study, we have investigated the effects of N-3 fatty acid supplem
entation on neuronal damage induced by permanent focal cerebral ischae
mia or pharmacological activation of striatal NMDA receptors. Weanling
rats were fed either a control diet or an N-3 supplemented diet (1.75
% by weight as N-3 fatty acids) for 6 weeks. N-3-supplemented animals
reduced ischaemic damage following middle cerebral artery occlusion (3
6%, p < 0.05), and excitotoxic damage induced by infusion of the selec
tive NMDA agonist (1-aminocyclobutane-cis-1,3-dicarboxylic acid, 43%,
p < 0.001) compared to the control-fed group. These data are consisten
t with the proposed role of arachidonic acid in ischaemic and excitoto
xic brain damage, and suggest that modest dietary supplementation with
N-3 fatty acids may offer benefit to populations at high risk of stro
ke.